Compile Data Set for Download or QSAR
Report error Found 16 Enz. Inhib. hit(s) with all data for entry = 50022180
TargetFree fatty acid receptor 1(Human)
National Institute of Diabetes and Digestive and Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50232250(2-(5-(naphthalen-1-ylmethylthio)-1,3,4-thiadiazol-...)
Affinity DataEC50:  1.80E+3nMAssay Description:Activity at FFAR1 expressed in HEK-EM293 cells assessed as calcium influx by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/11/2009
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
National Institute of Diabetes and Digestive and Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50232256(N-(3-phenoxybenzyl)-4-nitrobenzamide | CHEMBL25507...)
Affinity DataIC50: 2.80E+3nMAssay Description:Antagonist activity at FFAR1 expressed in HEK-EM293 cells assessed as inhibition calcium influx by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/11/2009
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
National Institute of Diabetes and Digestive and Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50232250(2-(5-(naphthalen-1-ylmethylthio)-1,3,4-thiadiazol-...)
Affinity DataEC50:  3.60E+3nMAssay Description:Agonist activity at FFAR1 expressed in HEK-EM293 cells assessed as calcium influx by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/11/2009
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
National Institute of Diabetes and Digestive and Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50232261(3-(4-nitrophenoxy)-N-phenylbenzamide | CHEMBL43816...)
Affinity DataIC50: 5.30E+3nMAssay Description:Antagonist activity at FFAR1 expressed in HEK-EM293 cells assessed as inhibition calcium influx by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/11/2009
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
National Institute of Diabetes and Digestive and Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50232249(6-(4-oxo-5-(thiophen-2-ylmethylene)-2-thioxothiazo...)
Affinity DataEC50:  6.60E+3nMAssay Description:Activity at FFAR1 expressed in HEK-EM293 cells assessed as calcium influx by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/11/2009
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
National Institute of Diabetes and Digestive and Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50232249(6-(4-oxo-5-(thiophen-2-ylmethylene)-2-thioxothiazo...)
Affinity DataEC50:  7.60E+3nMAssay Description:Agonist activity at FFAR1 expressed in HEK-EM293 cells assessed as calcium influx by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/11/2009
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
National Institute of Diabetes and Digestive and Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50232251(3-(3-(benzyloxy)benzylamino)benzoic acid | CHEMBL2...)
Affinity DataEC50:  8.20E+3nMAssay Description:Agonist activity at FFAR1 expressed in HEK-EM293 cells assessed as calcium influx by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/11/2009
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
National Institute of Diabetes and Digestive and Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50232252(6-(5-(naphthalen-1-ylmethylene)-4-oxo-2-thioxothia...)
Affinity DataEC50:  1.22E+4nMAssay Description:Agonist activity at FFAR1 expressed in HEK-EM293 cells assessed as calcium influx by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/11/2009
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
National Institute of Diabetes and Digestive and Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50232254(3-(4-(allyloxy)benzylamino)benzoic acid | CHEMBL25...)
Affinity DataEC50:  1.45E+4nMAssay Description:Agonist activity at FFAR1 expressed in HEK-EM293 cells assessed as calcium influx by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/11/2009
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
National Institute of Diabetes and Digestive and Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50232260(4-((5-(4-methoxybenzylthio)-1,3,4-thiadiazol-2-ylt...)
Affinity DataEC50:  1.51E+4nMAssay Description:Agonist activity at FFAR1 expressed in HEK-EM293 cells assessed as calcium influx by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/11/2009
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
National Institute of Diabetes and Digestive and Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50232259(4-(4-benzoylbenzamido)benzoic acid | CHEMBL404008)
Affinity DataEC50:  1.61E+4nMAssay Description:Agonist activity at FFAR1 expressed in HEK-EM293 cells assessed as calcium influx by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/11/2009
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
National Institute of Diabetes and Digestive and Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50232253(methyl 2-(5-(benzylthio)-1,3,4-thiadiazol-2-ylthio...)
Affinity DataEC50:  1.67E+4nMAssay Description:Agonist activity at FFAR1 expressed in HEK-EM293 cells assessed as calcium influx by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/11/2009
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
National Institute of Diabetes and Digestive and Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50232262(cid_1201156 | CHEMBL402053 | 4-(5-(furan-2-ylmethy...)
Affinity DataEC50:  1.68E+4nMAssay Description:Agonist activity at FFAR1 expressed in HEK-EM293 cells assessed as calcium influx by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/11/2009
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
National Institute of Diabetes and Digestive and Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50232258(4-(4-oxo-5-(thiophen-2-ylmethylene)-2-thioxothiazo...)
Affinity DataEC50:  1.90E+4nMAssay Description:Agonist activity at FFAR1 expressed in HEK-EM293 cells assessed as calcium influx by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/11/2009
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
National Institute of Diabetes and Digestive and Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50232257(4-(5-(4-fluorobenzylidene)-4-oxo-2-thioxothiazolid...)
Affinity DataEC50:  2.26E+4nMAssay Description:Agonist activity at FFAR1 expressed in HEK-EM293 cells assessed as calcium influx by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/11/2009
Entry Details Article
PubMed
TargetFree fatty acid receptor 1(Human)
National Institute of Diabetes and Digestive and Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50232255(4-(benzo[d][1,3]dioxol-5-ylmethylamino)benzoic aci...)
Affinity DataEC50:  2.46E+4nMAssay Description:Agonist activity at FFAR1 expressed in HEK-EM293 cells assessed as calcium influx by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/11/2009
Entry Details Article
PubMed